• Profile
Close

Long-term immune response to yellow fever vaccination in human immunodeficiency virus (HIV)–infected individuals depends on HIV RNA suppression status: Implications for vaccination schedule

Clinical Infectious Diseases Mar 25, 2018

Veit O, et al. - In human immunodeficiency virus (HIV)–infected individuals, the immune response over time to yellow fever vaccination (YFV) and the necessity for booster vaccination were investigated. The control of HIV replication at the time of vaccination was primarily influencing HIV-infected patients’ long-term immune response up to 10 years to YFV. Patients with successful combination antiretroviral therapy (cART) showed immune response up to 10 years similar to that of non-HIV-infected adults. A single YFV booster after 10 years was recommended for patients vaccinated on successful cART. However, an early booster might be required in those vaccinated with uncontrolled HIV RNA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay